Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Nikkiso Co., Ltd. (6376.T)
Tokyo, JP
Nikkiso Co., Ltd. is a global enterprise that operates across a diverse range of sectors, including industrial solutions, aerospace components, precision instruments, deep ultraviolet (DUV) LED technology, and medical devices. The company's operations are primarily organized into two main divisions: the Industrial Business segment and the Medical Business segment. The Industrial Business segment focuses on the development, production, sales, and maintenance of specialized industrial pumps, such as leak-proof pumps, accurate metering pumps, and cryogenic pumps vital for liquefied natural gas (LNG) transfer. This division also provides advanced water conditioning systems for thermal and nuclear power plants, along with integrated system products that combine water treatment capabilities with automation and other sophisticated functions. Furthermore, it supplies warm laminating systems, various electronic component manufacturing equipment, carbon fiber reinforced plastic (CFRP) products designed for civilian aircraft, and deep ultraviolet LEDs and their associated technologies. Within the Medical Business segment, Nikkiso is engaged in the manufacturing, distribution, and servicing of products and medical supplies crucial for kidney-related therapies, including hemodialysis, peritoneal dialysis, and continuous renal replacement therapy. Its key offerings encompass comprehensive dialysis systems, dialyzers, blood tubing lines, and powdered dialysate. This segment also produces blood glucose monitoring devices, air purification units, innovative ozone-water hand-washing systems, and microwave-based surgical instruments. Founded in 1950 as Nippon Kikai Keiso Kaisha Ltd., the company officially changed its name to Nikkiso Co., Ltd. in November 1968. Its corporate headquarters are located in Tokyo, Japan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.82% | +5.96% | +6.47% | +16.90% | +76.81% | +74.74% | +127.05% | +213.64% | +143.25% | +241.25% | +483.30% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Industrial - Machinery: +7.4%+1.1% Q1'26: +14.6% (vs Q1'25)
-
EPS growth Industrial - Machinery: +15.6%+71.6% ★ Q1'26: +41.5% (vs Q1'25)
-
FCF margin FCF growth · Industrial - Machinery: +38.2%+3.6% ★ Q1'26: -13.4% (vs Q1'25)
-
EBIT margin Industrial - Machinery: +10.0%+6.9% Q1'26: +6.2% (vs Q1'25)
-
ROIC Industrial - Machinery: +6.8%+5.3% Q1'26: +4.3% (vs Q1'25)
-
Share dilution Industrial - Machinery: +0.0%0.0% ★ Q1'26: -1.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Industrial - Machinery: -0.65×4.21× Q1'26: 4.53× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2014 actual |
Dec 2015 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
121.55B
est: 130.27B (-6.7%)
|
129.26B
est: 113.20B (+14.2%)
|
146.96B
est: 113.20B (+29.8%)
|
130.05B
est: 127.70B (+1.8%)
|
140.91B
est: 141.75B (-0.6%)
|
165.33B
est: 163.82B (+0.9%)
|
165.78B
est: 171.33B (-3.2%)
|
158.54B
est: 161.02B (-1.5%)
|
167.76B
est: 173.55B (-3.3%)
|
177.11B
est: 168.00B (+5.4%)
|
192.63B
est: 208.09B (-7.4%)
|
213.38B
est: 213.00B (+0.2%)
|
215.64B
est: 223.00B (-3.3%)
|
240.00B
240.00B – 240.00B
+7.6% YoY
|
263.00B
263.00B – 263.00B
+9.6% YoY
|
282.00B
282.00B – 282.00B
+7.2% YoY
|
| EBITDA |
14.66B
est: 17.09B (-14.2%)
|
16.09B
est: 14.85B (+8.3%)
|
14.03B
est: 14.85B (-5.5%)
|
12.17B
est: 16.76B (-27.3%)
|
12.58B
est: 18.60B (-32.3%)
|
16.19B
est: 21.49B (-24.7%)
|
19.86B
est: 22.48B (-11.7%)
|
17.66B
est: 21.13B (-16.4%)
|
12.37B
est: 22.77B (-45.7%)
|
6.36B
est: 22.04B (-71.1%)
|
15.01B
est: 38.83B (-61.3%)
|
17.53B
est: 39.75B (-55.9%)
|
26.16B
est: 41.61B (-37.1%)
|
44.79B
44.79B – 44.79B
+7.6% YoY
|
49.08B
49.08B – 49.08B
+9.6% YoY
|
52.62B
52.62B – 52.62B
+7.2% YoY
|
| EBIT |
9.42B
est: 9.89B (-4.7%)
|
9.07B
est: 8.60B (+5.5%)
|
5.13B
est: 8.60B (-40.4%)
|
7.41B
est: 9.70B (-23.6%)
|
7.34B
est: 10.76B (-31.9%)
|
9.85B
est: 12.44B (-20.8%)
|
10.87B
est: 13.01B (-16.5%)
|
8.87B
est: 12.23B (-27.5%)
|
2.51B
est: 13.18B (-80.9%)
|
-3.46B
est: 12.76B (-127.1%)
|
4.56B
est: 29.50B (-84.5%)
|
6.33B
est: 30.20B (-79.1%)
|
14.91B
est: 31.62B (-52.8%)
|
34.03B
34.03B – 34.03B
+7.6% YoY
|
37.29B
37.29B – 37.29B
+9.6% YoY
|
39.98B
39.98B – 39.98B
+7.2% YoY
|
| Net Income |
5.90B
est: 4.72B (+24.8%)
|
5.10B
est: 2.06B (+147.3%)
|
2.80B
est: 2.06B (+35.7%)
|
4.88B
est: 1.64B (+197.9%)
|
5.18B
est: 4.84B (+7.1%)
|
7.45B
est: 5.04B (+47.8%)
|
6.81B
est: 6.40B (+6.4%)
|
6.56B
est: 5.49B (+19.5%)
|
221.00M
est: 835.48M (-73.5%)
|
13.64B
est: 13.68B (-0.3%)
|
9.07B
est: 11.17B (-18.8%)
|
7.96B
est: 8.80B (-9.6%)
|
13.65B
est: 9.80B (+39.3%)
|
14.73B
14.73B – 14.73B
+50.2% YoY
|
16.96B
16.96B – 16.96B
+15.2% YoY
|
19.50B
19.50B – 19.50B
+15.0% YoY
|
| SGA |
24.76B
est: 31.61B (-21.7%)
|
—
est: 27.47B (-100.0%)
|
42.32B
est: 27.47B (+54.1%)
|
34.23B
est: 30.99B (+10.4%)
|
36.96B
est: 34.40B (+7.4%)
|
42.15B
est: 39.75B (+6.0%)
|
37.62B
est: 41.58B (-9.5%)
|
37.50B
est: 39.07B (-4.0%)
|
42.19B
est: 42.11B (+0.2%)
|
42.90B
est: 40.77B (+5.2%)
|
39.90B
est: 47.32B (-15.7%)
|
43.52B
est: 48.44B (-10.2%)
|
50.10B
est: 50.72B (-1.2%)
|
54.58B
54.58B – 54.58B
+7.6% YoY
|
59.81B
59.81B – 59.81B
+9.6% YoY
|
64.13B
64.13B – 64.13B
+7.2% YoY
|
| EPS |
76.46
est: 71.24 (+7.3%)
|
66.12
est: 31.10 (+112.6%)
|
49.77
est: 31.10 (+60.0%)
|
66.08
est: 24.73 (+167.2%)
|
72.82
est: 72.99 (-0.2%)
|
104.63
est: 75.98 (+37.7%)
|
95.67
est: 96.54 (-0.9%)
|
92.08
est: 82.80 (+11.2%)
|
3.11
est: 12.60 (-75.3%)
|
195.23
est: 206.30 (-5.4%)
|
137.07
est: 168.45 (-18.6%)
|
120.15
est: 132.80 (-9.5%)
|
206.22
est: 147.90 (+39.4%)
|
222.20
222.20 – 222.20
+50.2% YoY
|
255.90
255.90 – 255.90
+15.2% YoY
|
294.20
294.20 – 294.20
+15.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | A | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-14 | A | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-13 | A | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-12 | A | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-11 | A | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-08 | A | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-07 | A | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-01 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-30 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-28 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-27 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-24 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-17 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Smart City Infrastructure UCITS ETF CT2B.AS | 0.21% | 104.3K | 0.40% |
| 2 | iShares Smart City Infrastructure UCITS ETF CITY.AS | 0.21% | 883.4K | 0.40% |
| 3 | State Street SPDR S&P International Small Cap ETF GWX | 0.20% | 1.76M | 0.40% |
| 4 | iShares International Developed Small Cap Value Factor ETF ISVL | 0.18% | 567.9K | 0.31% |
| 5 | Dimensional - International Small Cap Value ETF DISV | 0.16% | 7.72M | 0.42% |
| 6 | Avantis International Small Cap Value ETF AVDV | 0.11% | 21.10M | 0.36% |
| 7 | FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund TLTD | 0.08% | 516.3K | 0.41% |
| 8 | iShares MSCI Japan Small Cap UCITS ETF IDJP.L | 0.07% | 402.4K | 0.58% |
| 9 | iShares MSCI Japan Small-Cap ETF SCJ | 0.06% | 165.4K | 0.50% |
| 10 | Dimensional - International Small Cap ETF DFIS | 0.06% | 3.70M | 0.39% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kazuhiko Sugimoto | Executive Officer & Head of Medical Factory, Kanazawa Plant | — | male |
| Kazuo Nakatsuru | Executive Officer and Senior Executive VP & Director of Cryogenic Industries, Inc. | — | — |
| Kenji Saito | Managing Executive Officer, Head of Industrial Unit, Head of Industrial Division & Director | — | male |
| Koichi Kato | President, Chief Executive Officer & Representative Director | — | male |
| Masaharu Murakami | Head of Corporate Unit, Head of Corporate Division, Corporate Director Executive Officer & Director | — | — |
| Masaru Yamamura | Managing Executive Officer, Head of Medical Div., Medical Unit, Shizuoka office & Director | — | male |
| Naoki Yokota | Executive Officer & Deputy GM of Aerospace Business | — | — |
| Susumu Koito | Executive Officer, GM of Corporate Unit and GM of Administration & Corporate Planning | — | — |
| Takayoshi Izumi | GM of Medical Plant, Kanazawa Factory | — | — |
| Takeshi Iwaoka | Executive Officer & Head of Aerospace Division | — | — |
| Yoshihiko Kinoshita | Executive Officer, Head of Nikkiso Institute of Research & Technology and Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 6376.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
